SCHEMBL24826937

SCHEMBL24826937

Cc1ccccc1Oc1cc(N)c2ccccc2c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 2/20 0.46
BCAT1 P54687 2/20 0.46
AR P10275 3/20 0.43
PKM P14618 1/20 0.42
G6PD P11413 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
ACHE P22303 4/20 0.38
BCHE P06276 3/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
IDO1 P14902 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24825907 0.78 AR (0.48) BCAT2BCAT1ARPKMSMN1; SMN2
SCHEMBL30046063 0.73 LMNA (0.49) BCAT2BCAT1ARSMN1; SMN2MEN1
SCHEMBL395415 0.73 ALDH1A1 (0.54) ARSMN1; SMN2MEN1NPC1TSHR
SCHEMBL29597724 0.73 ALDH1A1 (0.54) ARSMN1; SMN2MEN1NPC1TSHR
SCHEMBL29779327 0.72 MEN1 (0.47) BCAT2BCAT1ARSMN1; SMN2MEN1
SCHEMBL24826943 0.72 MEN1 (0.47) BCAT2BCAT1ARSMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL10424097 0.72 SMN1; SMN2 (0.47) ARSMN1; SMN2MEN1NPC1TSHR
SCHEMBL29637724 0.72 TSHR (0.65) ARSMN1; SMN2MEN1NPC1TSHR
SCHEMBL127000 0.72 TSHR (0.65) ARSMN1; SMN2MEN1NPC1TSHR
SCHEMBL25500740 0.70 AR (0.60) ARSMN1; SMN2MEN1NPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411381-A1 PYRIMIDINEDIONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411381-A1 PYRIMIDINEDIONE DERIVATIVES DPYD, TYMP, TYMS BCAT2 3754/4885BCAT1 2999/4885AR 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.